Literature DB >> 2181401

A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene.

M D Walker1, C W Park, A Rosen, A Aronheim.   

Abstract

Cell specific expression of the insulin gene is achieved through transcriptional mechanisms operating on multiple DNA sequence elements located in the 5' flanking region of the gene. Of particular importance in the rat insulin I gene are two closely similar 9 bp sequences (IEB1 and IEB2): mutation of either of these leads to 5-10 fold reduction in transcriptional activity. We have screened an expression cDNA library derived from mouse pancreatic endocrine beta cells with a radioactive DNA probe containing multiple copies of the IEB1 sequence. A cDNA clone (A1) isolated by this procedure encodes a protein which shows efficient binding to the IEB1 probe, but much weaker binding to either an unrelated DNA probe or to a probe bearing a single base pair insertion within the recognition sequence. DNA sequence analysis indicates a protein belonging to the helix-loop-helix family of DNA-binding proteins. The ability of the protein encoded by clone A1 to recognize a number of wild type and mutant DNA sequences correlates closely with the ability of each sequence element to support transcription in vivo in the context of the insulin 5' flanking DNA. We conclude that the isolated cDNA may encode a transcription factor that participates in control of insulin gene expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181401      PMCID: PMC330430          DOI: 10.1093/nar/18.5.1159

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  37 in total

1.  Isolation, characterization, and DNA sequence of the rat somatostatin gene.

Authors:  M A Tavianini; T E Hayes; M D Magazin; C D Minth; J E Dixon
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

2.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

3.  Cell-specific expression controlled by the 5'-flanking region of insulin and chymotrypsin genes.

Authors:  M D Walker; T Edlund; A M Boulet; W J Rutter
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

4.  B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo.

Authors:  A Ephrussi; G M Church; S Tonegawa; W Gilbert
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  Multiple ribosomal RNA cleavage pathways in mammalian cells.

Authors:  L H Bowman; B Rabin; D Schlessinger
Journal:  Nucleic Acids Res       Date:  1981-10-10       Impact factor: 16.971

6.  Assembly of the mitochondrial membrane system. CBP6, a yeast nuclear gene necessary for synthesis of cytochrome b.

Authors:  C L Dieckmann; A Tzagoloff
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

7.  Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.

Authors:  D Hanahan
Journal:  Nature       Date:  1985 May 9-15       Impact factor: 49.962

8.  Yeast RNA polymerase II genes: isolation with antibody probes.

Authors:  R A Young; R W Davis
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

9.  The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.

Authors:  J D Mellentin; C Murre; T A Donlon; P S McCaw; S D Smith; A J Carroll; M E McDonald; D Baltimore; M L Cleary
Journal:  Science       Date:  1989-10-20       Impact factor: 47.728

10.  High incidence of B cell lymphomas derived from thymectomized AKR mice expressing TL.4 antigen.

Authors:  A Peled; N Haran-Ghera
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  30 in total

1.  Insulin gene expression in nonexpressing cells appears to be regulated by multiple distinct negative-acting control elements.

Authors:  S R Cordle; J Whelan; E Henderson; H Masuoka; P A Weil; R Stein
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

2.  B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.

Authors:  C F Voliva; A Aronheim; M D Walker; B M Peterlin
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding.

Authors:  T Chakraborty; T J Brennan; L Li; D Edmondson; E N Olson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

4.  Functional analysis of the nuclear LIM domain interactor NLI.

Authors:  L W Jurata; G N Gill
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 5.  The endocrine pancreas and its tumors.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  1993-09       Impact factor: 3.943

6.  Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice.

Authors:  F J Naya; H P Huang; Y Qiu; H Mutoh; F J DeMayo; A B Leiter; M J Tsai
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

7.  Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters.

Authors:  D Melloul; Y Ben-Neriah; E Cerasi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes.

Authors:  M S German; L G Moss; J Wang; W J Rutter
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

9.  Regulatory regions of rat insulin I gene necessary for expression in transgenic mice.

Authors:  F Dandoy-Dron; E Monthioux; J Jami; D Bucchini
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

10.  The E2A gene product contains two separable and functionally distinct transcription activation domains.

Authors:  A Aronheim; R Shiran; A Rosen; M D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.